GRN and primary progressive aphasia: Better recognition of the phenotypic presentations of GRN-related PPA are likely to trigger earlier genetic testing and in turn lead to improvements in management, including allowing people to enter clinical trials for those with GRN mutations and family members to access genetic counselling.